FluoGuide > Fluoguide: FluoGuide A/S presents at

Klik her for at følge aktiekursen i realtid. Jeg har fulgt den et stykke tid.

10.21.2021
  1. Share information - FluoGuide, fluoguide kurs
  2. FluoGuide A/S publishes interim report for the period January
  3. FluoGuide > Fluoguide: Dorthe Grønnegaard Mejer
  4. FluoGuide > Fluoguide: First patient enrolled in the
  5. Extraordinary General Meeting | Placera
  6. Aktieanalyser og kursmål
  7. Extraordinary General Meeting - FluoGuide
  8. FluoGuide - Intelligent surgical targeting
  9. Fluoguide sikrer sig patent og mulighed for flere partnerskaber
  10. Spotlight Denmark | Spotlight
  11. FluoGuide > Fluoguide: FluoGuide gets green light to
  12. Fluoguide - Home | Facebook
  13. FluoGuide har fået publiceret resultater med cancerprodukt
  14. Extraordinary General Meeting - Fluoguide
  15. FluoGuide (FLUO) aktie - Nordnet
  16. FluoGuide A/S and LI-COR Biosciences sign agreement to
  17. ISS A/S (ISS) aktie - Nordnet

Share information - FluoGuide, fluoguide kurs

Købte en sjat i kurs 12, 1.Og synes.
Fluoguide 6937 visninger Tilbage til oversigten.FluoGuide A S.
Hjælper kirurgen til at fjerne al cancer første gang ved oplysning af cancervævet.Køb ISS A S.

FluoGuide A/S publishes interim report for the period January

Aktien.
FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.
Se C25 og kurser fra danske.
Svenske.
Norske.
Engelske.
Amerikanske.
Hollandske. Fluoguide kurs

FluoGuide > Fluoguide: Dorthe Grønnegaard Mejer

  • Belgiske og franske markeder.
  • Kursmål 0- 6 mdr.
  • Kursmål 0- 6 mdr udbyttekorrigeret.
  • Solar*.
  • Kurs 450.
  • Til aktionærerne i FluoGuide A S.
  • Dansk version nedenfor.

FluoGuide > Fluoguide: First patient enrolled in the

H+ H*. Kurs 151.Copenhagen. Denmark.17 February - FluoGuide A S. Fluoguide kurs

H+ H*.
Kurs 151.

Extraordinary General Meeting | Placera

FluoGuide or the Company. Is pleased to announce that the dose escalation committee have approved initiation of the fourth dose level in the ongoing clinical phase I II trial evaluating safety and efficacy of FG001 in patients with high grade glioma undergoing neurosurgery. Hos Nordnet kan du handle fra 0 kr. FluoGuide acquires rights to photothermal therapy using FG001 Tue. 13 04 CET. Fluoguide kurs

Aktieanalyser og kursmål

Kurs 15, 1. Kursmål 0- 6 mdr.I kurtage. The results will be evaluated and made available as earlier communicated in the Company' s interim report from second quarter.Published in August. Saniona*. Fluoguide kurs

Kurs 15, 1.
Kursmål 0- 6 mdr.

Extraordinary General Meeting - FluoGuide

Kurs 25, 5.Kursmål 0- 6 mdr.
TCM Group*.Kurs 140.
FluoGuide är ett danskt bolag verksamma inom medicinteknik.Hos Nordnet kan du handle fra 0 kr.
Vejen til mål er lang med forestående kliniske studier.Men ambitionerne er store.

FluoGuide - Intelligent surgical targeting

Beskrivelse af aktieliste. FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.Ved at bruge vores tjenester. Fluoguide kurs

Beskrivelse af aktieliste.
FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

Fluoguide sikrer sig patent og mulighed for flere partnerskaber

  • Accepterer du vores brug af cookies.
  • The right to a dividend applies to investors who are registered as shareholders in FluoGuide on the record day for the distribution of profit.
  • Janu To the shareholders of FluoGuide A S.
  • FluoGuide är ett danskt bolag verksamma inom medicinteknik.
  • Bolaget fokuserar på behandling av cancer.
  • Med störst fokus på utveckling av produkter som vägled.

Spotlight Denmark | Spotlight

The agreement will help FluoGuide broaden its portfolio of uPAR- targeted products with features unique to IRDye 800CW. Such as deep tissue targeting.Klik her for at følge aktiekursen i realtid. Cookies hjælper os med at levere vores tjenester.Omtrent 6, 4 mio. Køb FluoGuide. Fluoguide kurs

The agreement will help FluoGuide broaden its portfolio of uPAR- targeted products with features unique to IRDye 800CW.
Such as deep tissue targeting.

FluoGuide > Fluoguide: FluoGuide gets green light to

Aktien.
The ” Company”.
To be held on.
FluoGuide A S is a Denmark- based provider of solutions for maximizing surgical outcome through intelligent targeting.
Copenhagen.
Denmark.
13 August – FluoGuide A S. Fluoguide kurs

Fluoguide - Home | Facebook

“ FluoGuide” or “ the Company”.
Has signed a non- exclusive supply and licensing agreement with the US company LI- COR Biosciences.
Til aktionærerne i FluoGuide A S.
Dansk version følger nedenfor.
The Company develops surgical solutions.
Which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system.
Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i.
Fluoguide has 1, 618 members. Fluoguide kurs

FluoGuide har fået publiceret resultater med cancerprodukt

BioStock Virtual Investor Pitch with FluoGuide. April 23. Aktier - Kurser. Markedsdata og nyheder. The ” Company”. To be held on. Fluoguide kurs

Extraordinary General Meeting - Fluoguide

Monday 17 February at 11 00. FluoGuide’ s first product. FG001. Improves precision in cancer surgery by lighting up the cancer and its invasive growth into the surrounding tissue. FluoGuide is pleased to inform that the first patient has now been enrolled in the dose escalation phase of the clinical trial. Fluoguide kurs

FluoGuide (FLUO) aktie - Nordnet

  • Well we want to help companies to focus on their business and growth.
  • And therefore your dedicated expert is on your back and call to give guidance in rules.
  • Regulations and best practice.
  • FluoGuide has previously communicated its anticipation of a clean outcome of these studies which has now been confirmed.
  • Informationen bygger på dagsaktuellt ägande hos Avanzas kunder och presenteras för bolag som ägs av minst 100 kunder.

FluoGuide A/S and LI-COR Biosciences sign agreement to

I kurtage.
Fluoguide.
Copenhagen.
Denmark.
14 August – FluoGuide A S.
“ FluoGuide” or “ the Company”.
Today releases its results for the period 1 January – 30 June.
Copenhagen. Fluoguide kurs

ISS A/S (ISS) aktie - Nordnet

“ FluoGuide” or the “ Company”. Is pleased to announce that the Company has acquired worldwide exclusive rights to use FG001 for photothermal therapy in combination with dedicated light source.FluoGuide A S publishes interim report for the period January - June Fri. 08 19 CET. Fluoguide kurs

“ FluoGuide” or the “ Company”.
Is pleased to announce that the Company has acquired worldwide exclusive rights to use FG001 for photothermal therapy in combination with dedicated light source.